TipRanks
Bafna Pharmaceuticals Limited (IN:BAFNAPH)
:BAFNAPH
India Market
BAFNAPH
Bafna Pharmaceuticals Limited
RESEARCH TOOLSreports
Want to see IN:BAFNAPH full AI Analyst Report?

Bafna Pharmaceuticals Limited (BAFNAPH) Ratios

0 Followers

Bafna Pharmaceuticals Limited Ratios

IN:BAFNAPH's free cash flow for Q1 2027 was ₹0.39. For the 2027 fiscal year, IN:BAFNAPH's free cash flow was decreased by ₹ and operating cash flow was ₹0.04. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 25Mar 24Mar 23
Liquidity Ratios
Current Ratio
 0.00 1.57 1.63 1.75 1.88
Quick Ratio
 0.00 1.06 1.09 1.20 1.40
Cash Ratio
 0.00 0.04 0.07 0.03 0.17
Solvency Ratio
 -0.15 0.22 0.13 0.18 0.30
Operating Cash Flow Ratio
 0.00 0.21 0.38 0.18 0.11
Short-Term Operating Cash Flow Coverage
 0.00 0.60 1.38 0.70 0.34
Net Current Asset Value
₹ 961.50M₹ 102.69M₹ 164.55M₹ 276.27M₹ 311.83M
Leverage Ratios
Debt-to-Assets Ratio
 0.00 0.21 0.18 0.17 0.18
Debt-to-Equity Ratio
 0.00 0.39 0.33 0.30 0.31
Debt-to-Capital Ratio
 0.00 0.28 0.25 0.23 0.24
Long-Term Debt-to-Capital Ratio
 0.00 0.16 0.14 0.12 0.10
Financial Leverage Ratio
 0.00 1.83 1.81 1.83 1.76
Debt Service Coverage Ratio
 5.98 0.89 0.70 0.92 1.13
Interest Coverage Ratio
 4.19 2.70 2.30 10.38 5.10
Debt to Market Cap
 0.00 0.14 0.16 0.13 0.12
Interest Debt Per Share
 1.10 17.36 13.05 11.29 10.55
Net Debt to EBITDA
 0.00 1.71 2.10 1.57 0.80
Profitability Margins
Gross Profit Margin
22.77%13.37%11.57%29.66%33.60%
EBIT Margin
7.01%9.71%4.72%6.32%11.84%
EBITDA Margin
11.32%13.75%8.07%9.60%16.46%
Operating Profit Margin
8.00%6.56%4.31%15.59%9.01%
Pretax Profit Margin
5.30%7.28%2.85%4.82%10.07%
Net Profit Margin
5.39%7.37%2.85%4.82%9.83%
Continuous Operations Profit Margin
5.39%7.37%2.85%4.82%9.83%
Net Income Per EBT
101.69%101.18%100.00%100.00%97.60%
EBT Per EBIT
66.25%111.09%66.05%30.92%111.78%
Return on Assets (ROA)
0.00%6.32%2.71%4.98%8.75%
Return on Equity (ROE)
8.31%11.54%4.90%9.09%15.44%
Return on Capital Employed (ROCE)
0.00%8.34%6.21%25.39%12.50%
Return on Invested Capital (ROIC)
0.00%7.16%5.45%22.16%10.39%
Return on Tangible Assets
0.00%6.32%2.71%5.04%8.85%
Earnings Yield
0.82%4.29%2.34%3.88%5.84%
Efficiency Ratios
Receivables Turnover
 0.00 3.42 3.63 3.36 2.80
Payables Turnover
 0.00 4.17 4.17 3.03 2.69
Inventory Turnover
 0.00 4.51 4.59 3.62 3.45
Fixed Asset Turnover
 0.00 1.77 2.21 3.01 2.87
Asset Turnover
 0.00 0.86 0.95 1.03 0.89
Working Capital Turnover Ratio
 8.90 4.61 3.98 3.75 3.31
Cash Conversion Cycle
 0.00 99.98 92.50 89.00 100.46
Days of Sales Outstanding
 0.00 106.64 100.59 108.67 130.21
Days of Inventory Outstanding
 0.00 80.86 79.48 100.88 105.88
Days of Payables Outstanding
 0.00 87.52 87.57 120.55 135.63
Operating Cycle
 0.00 187.50 180.07 209.55 236.09
Cash Flow Ratios
Operating Cash Flow Per Share
 3.72 5.00 8.24 4.01 2.09
Free Cash Flow Per Share
 -2.84 -5.53 -0.98 -2.58 -1.38
CapEx Per Share
 6.56 10.52 9.23 6.59 3.47
Free Cash Flow to Operating Cash Flow
 -0.76 -1.11 -0.12 -0.64 -0.66
Dividend Paid and CapEx Coverage Ratio
 0.57 0.47 0.89 0.61 0.60
Capital Expenditure Coverage Ratio
 0.57 0.47 0.89 0.61 0.60
Operating Cash Flow Coverage Ratio
 0.00 0.32 0.69 0.39 0.22
Operating Cash Flow to Sales Ratio
 0.06 0.08 0.13 0.06 0.04
Free Cash Flow Yield
-0.79%-5.05%-1.31%-3.21%-1.68%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 115.12 23.31 42.51 25.80 17.11
Price-to-Sales (P/S) Ratio
 6.20 1.72 1.22 1.24 1.68
Price-to-Book (P/B) Ratio
 9.86 2.69 2.09 2.35 2.64
Price-to-Free Cash Flow (P/FCF) Ratio
 -126.11 -19.79 -76.05 -31.12 -59.39
Price-to-Operating Cash Flow Ratio
 101.81 21.88 9.08 19.99 39.17
Price-to-Earnings Growth (PEG) Ratio
 -20.09 0.14 -0.98 -0.74 0.15
Price-to-Fair Value
 9.86 2.69 2.09 2.35 2.64
Enterprise Value Multiple
 54.80 14.21 17.16 14.53 11.01
Enterprise Value
 8.96B 2.94B 2.02B 2.13B 2.09B
EV to EBITDA
 54.80 14.21 17.16 14.53 11.01
EV to Sales
 6.20 1.95 1.38 1.39 1.81
EV to Free Cash Flow
 -126.11 -22.50 -86.67 -34.89 -64.02
EV to Operating Cash Flow
 96.21 24.87 10.34 22.41 42.22
Tangible Book Value Per Share
 38.41 40.63 35.79 33.47 30.42
Shareholders’ Equity Per Share
 38.41 40.63 35.79 34.22 31.05
Tax and Other Ratios
Effective Tax Rate
 -0.02 -0.01 0.00 0.00 0.02
Revenue Per Share
 57.72 63.64 61.56 64.53 48.76
Net Income Per Share
 3.11 4.69 1.75 3.11 4.79
Tax Burden
 1.02 1.01 1.00 1.00 0.98
Interest Burden
 0.76 0.75 0.60 0.76 0.85
Research & Development to Revenue
 0.00 0.00 0.02 0.01 <0.01
SG&A to Revenue
 0.08 0.07 0.15 0.13 0.01
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.83 1.07 4.70 1.29 0.42
Currency in INR